AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Suglow G 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

BRD MediLabs

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Suglow G 2mg/500mg Tablet

Diabetic patients using Glucovance (a 2mg/500mg combination tablet) should be aware that it's an antidiabetic medication combining two active components for adult type 2 diabetes management. This medication regulates blood sugar, requiring consistent daily intake at the same time, ideally with food. Dosage adjustments depend on individual response and blood glucose monitoring, as determined by your physician. Discontinuing Glucovance without medical supervision can lead to elevated blood sugar, increasing the risk of complications such as kidney damage, vision loss, neuropathy, and limb amputation. Therefore, continuous use, alongside a doctor-approved diet, exercise regimen, and weight management plan, is vital for optimal diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects encompass altered taste perception, nausea, diarrhea, abdominal discomfort, headaches, and upper respiratory infections; weight gain is also a possibility. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment, as it may influence suitability. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are typically recommended.

Uses of Suglow G 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Suglow G 2mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Suglow G 2mg/500mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Suglow G 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Suglow G 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Suglow G 2mg/500mg Tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.

How Suglow G 2mg/500mg Tablet works:

Suglow G tablets (2mg/500mg) combine the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Suglow G 2mg/500mg tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Suglow G 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Administering Suglow G 2mg/500mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by abnormally high or low blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Suglow G 2mg/500mg tablets, as dosage modification may be necessary. Consult your physician for guidance. In cases of severe kidney disease, Suglow G 2mg/500mg tablets are contraindicated. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Suglow G 2mg/500mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, a low initial dose is typical; however, the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Suglow G 2mg/500mg Tablet :

For forgotten Suglow G 2mg/500mg Tablet doses, take the medication immediately if you remember. If your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Suglow G 2mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Diabetes medication

FAQs on Suglow G 2mg/500mg Tablet

Retain this medication within its original, sealed container or packaging. Follow the storage guidelines printed on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential adverse effect of Suglow G 2mg/500mg Tablet. Also termed Metformin-associated lactic acidosis (MALA), this rare but dangerous complication is particularly risky for individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Suglow G 2mg/500mg Tablet use and seek immediate medical attention.
Suglow G, a 2mg/500mg tablet containing glimepiride and metformin, manages type 2 diabetes mellitus (DM) in adults. This dual-action medication enhances glycemic control when combined with a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, thus reducing blood glucose. Metformin acts by decreasing hepatic glucose production and increasing insulin responsiveness. This formulation is unsuitable for type 1 DM.
Suglow G 2mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal discomfort, diarrhea, and headache. Rare but potentially serious adverse reactions such as lactic acidosis may occur. Prolonged treatment may result in vitamin B12 deficiency.
Prolonged use of Suglow G 2mg/500mg tablets can indeed lead to Vitamin B12 deficiency. This medication impairs the stomach's absorption of Vitamin B12. Untreated deficiency may result in anemia, neurological issues such as tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and impaired balance. To mitigate these risks, supplemental Vitamin B12 intake, at least annually, is recommended by some studies.
Indeed, taking Suglow G 2mg/500mg tablets can lead to hypoglycemia (low blood glucose). This condition manifests as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concurrent use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Always carry a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Suglow G 2mg/500mg tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Suglow G 2mg/500mg Tablet
71
MRP 86
17% off